BRCA2 mutations in hereditary breast and ovarian cancer in France

被引：0

作者：

SerovaSinilnikova, OM

Boutrand, L

StoppaLyonnet, D

BressacdePaillerets, B

Dubois, V

Lasset, C

Janin, N

Bignon, YJ

Longy, M

Maugard, C

Lidereau, R

Leroux, D

Frebourg, T

Mazoyer, S

Lenoir, GM

机构：

[1] CTR INT RECH CANC,F-69372 LYON 08,FRANCE

[2] CNRS,GENET LAB,UMR5641,LYON,FRANCE

[3] HOP EDOUARD HERRIOT,LYON,FRANCE

[4] CTR LEON BERARD,F-69373 LYON,FRANCE

[5] INST CURIE,PARIS,FRANCE

[6] INST GUSTAVE ROUSSY,VILLEJUIF,FRANCE

[7] CTR JEAN PERRIN,CLERMONT FERRAN,FRANCE

[8] CTR RENE GAUDUCHEAU,F-44035 NANTES,FRANCE

[9] INST BERGONIE,BORDEAUX,FRANCE

[10] CTR RENE HUGUENIN,ST CLOUD,FRANCE

[11] CHU GRENOBLE,F-38043 GRENOBLE,FRANCE

[12] CHR ROUEN,HOP CHARLES NICOLLE,ROUEN,FRANCE

来源：

AMERICAN JOURNAL OF HUMAN GENETICS | 1997年 / 60卷 / 05期

关键词：

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

引用

下载

页码：1236 / 1239

页数：4

共 50 条

[1] Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2
Petrucelli, Nancie
Daly, Mary B.
Feldman, Gerald L.
GENETICS IN MEDICINE, 2010, 12 (05) : 245 - 259
[2] BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer
Thomassen, Mads
Hansen, Thomas V. O.
Borg, Ake
Lianee, Henriette Theilmann
Wikman, Friedrik
Pedersen, Inge Sokilde
Bisgaard, Marie Luise
Nielsen, Finn C.
Kruse, Torben A.
Gerdes, Anne-Marie
ACTA ONCOLOGICA, 2008, 47 (04) : 772 - 777
[3] BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer
Pristauz G.
Geigl J.B.
Petru E.
Wiener Medizinische Wochenschrift, 2010, 160 (7-8) : 158 - 162
[4] Germline mutations in BRCA1 and BRCA2 genes in the Czech hereditary forms of breast/ovarian cancer
Machackova, E
Navratilova, M
Pavlu, H
Valik, D
Hruba, M
Foretova, L
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 83 - 83
[5] Analysis of BRCA1 and BRCA2 mutations in an Iranian family with hereditary breast and ovarian cancer syndrome
Moslehi, R
Kariminejad, MH
Ghaffari, V
Narod, S
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 117A (03) : 304 - 305
[6] Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families
Cierniková, S
Tomka, M
Kovác, M
Stevurková, V
Zajac, V
NEOPLASMA, 2006, 53 (02) : 97 - 102
[7] Prevalence of BRCA1 and BRCA2 founder mutations in Brazilian hereditary breast and ovarian cancer families
Ewald, I. P.
Vargas, F. R.
Moreira, M. A.
Filho, C. M.
da Cunha, D. R.
Ramos, J. P.
Ribeiro, P. L.
Caleffi, M.
Giugliani, R.
Ashton-Prolla, P.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[8] Novel BRCA1 and BRCA2 pathogenic mutations in Slovene hereditary breast and ovarian cancer families
Novakovic, Srdjan
Milatovic, Masa
Cerkovnik, Petra
Stegel, Vida
Krajc, Mateja
Hocevar, Marko
Zgajnar, Janez
Vakselj, Ales
INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 41 (05) : 1619 - 1627
[9] Survival in hereditary breast cancer associated with germline mutations of BRCA2
Verhoog, LC
Brekelmans, CTM
Seynaeve, C
Dahmen, G
van Geel, AN
Bartels, CCM
Tilanus-Linthorst, MMA
Wagner, A
Devilee, P
Halley, DJJ
van den Ouweland, AMW
Meijers-Heijboer, EJ
Klijn, JGM
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (11) : 3396 - 3402
[10] BRCA1 and BRCA2 mutations in Germany - indications for testing in hereditary breast and ovarian cancer families.
Schwarz-Boeger, U
Schmutzler, RK
Bastert, G
Bender, HG
Beckmann, MW
Caffier, H
Crohns, C
Deininger, J
Dietl, J
Ditsch, N
Distler, W
Estevez-Schwarz, L
Hepp, H
Herroeder, N
Huebbel, V
Huettner, C
Jackisch, C
Jonat, W
Kandel, M
Kast, K
Kaufmann, M
Krapfl-Gast, AS
Kreienberg, R
Kuschel, B
Kuschel, B
Luck, H
Meindl, A
von Minckwitz, G
Nestle-Kraemling, C
Paepke, S
Prieshof, B
Rensing, K
Rhiem, KA
Schaeffer, MA
Straub, L
Untch, M
Kiechle, T
BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S154 - S155

← 1 2 3 4 5 →